Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Lipodystrophy, Congenital Generalized
- A Extension Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance ( EMPIRE-02 )
- Study of REGN4461, a Leptin Receptor Agonist Antibody, in Patients With Generalized Lipodystrophy
- Immunogenicity of Metreleptin in Patients With Generalized Lipodystrophy
- A Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance
- Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
- Trial of Leptin Replacement Therapy in Patients With Lipodystrophy